✅ Manages sickle cell anemia
✅ Reduces frequency of painful crises
✅ Controls blood cell production
✅ Prevents clot formation
✅ Lowers risk of stroke

Hydrosar contains Hydroxyurea.

Product Overview

Hydrosar is a medication containing the active ingredient Hydroxyurea. It is a cytotoxic agent that works by inhibiting the synthesis of DNA, thereby preventing the proliferation of cancer cells. Hydrosar is available in various forms, including capsules and tablets, and is commonly prescribed for the treatment of certain types of cancer, including chronic myeloid leukemia (CML), sickle cell disease, and certain types of solid tumors. This medication is typically used in combination with other cancer treatments or as a standalone therapy, depending on the specific type and stage of cancer.


Hydrosar is primarily used in the treatment of various types of cancer, including chronic myeloid leukemia (CML), where it helps reduce the number of cancerous cells in the blood and bone marrow. It is also indicated for the management of sickle cell disease, where it increases the production of fetal hemoglobin, reducing the frequency of painful vaso-occlusive crises. Additionally, Hydrosar may be prescribed for the treatment of certain types of solid tumors, such as head and neck cancers, melanoma, and ovarian cancer.

How to Use

Hydrosar is typically taken orally in the form of capsules or tablets, with or without food, as directed by a healthcare professional. The dosage and duration of treatment depend on the type and stage of cancer being treated, as well as the patient’s overall health and response to therapy. It is important to swallow the medication whole with a full glass of water and not to crush, chew, or open the capsules or tablets unless instructed otherwise by your doctor.

How it Works

Hydroxyurea, the active ingredient in Hydrosar, works by inhibiting the enzyme ribonucleotide reductase, which is involved in the synthesis of DNA. By blocking this enzyme, Hydroxyurea prevents cancer cells from replicating and proliferating, ultimately leading to cell death. Additionally, Hydroxyurea increases the production of fetal hemoglobin in patients with sickle cell disease, which helps improve the deformability of red blood cells and reduce the risk of vaso-occlusive crises.

Dosage and Administration

The dosage of Hydrosar varies depending on the type of cancer being treated, the patient’s weight, and other factors. It is important to follow the dosage instructions provided by your doctor or healthcare provider carefully. Hydrosar is typically taken once daily, but the frequency and duration of treatment may vary. It is important not to miss any doses and to take the medication exactly as prescribed to achieve the best possible outcomes.


Hydrosar offers several benefits for individuals undergoing cancer treatment. It helps reduce the number of cancer cells in the blood and bone marrow, slowing down the progression of diseases such as chronic myeloid leukemia (CML). In patients with sickle cell disease, Hydrosar increases the production of fetal hemoglobin, reducing the frequency and severity of painful vaso-occlusive crises. Additionally, Hydrosar may help shrink certain types of solid tumors, improving overall survival rates and quality of life for cancer patients.

Common Side Effects

Common side effects of Hydrosar may include nausea, vomiting, diarrhea, loss of appetite, headache, dizziness, and fatigue. These side effects are usually mild to moderate in severity and may improve over time as the body adjusts to the medication. However, if any side effects persist or worsen, it is important to contact your healthcare provider for further evaluation and management.


Hydrosar may cause bone marrow suppression, which can lead to decreased blood cell counts, including white blood cells, red blood cells, and platelets. This can increase the risk of infections, anemia, and bleeding. Regular blood tests are required to monitor blood cell counts during treatment with Hydrosar. Additionally, Hydrosar may increase the risk of secondary malignancies, such as leukemia or skin cancer, especially with long-term use. Patients should be closely monitored for any signs or symptoms of these conditions.

Storage Information

Hydrosar should be stored at room temperature away from moisture and heat. Keep the medication out of reach of children and pets. Do not use Hydrosar after the expiration date printed on the label. If you have any unused or expired medication, dispose of it properly according to local regulations or guidelines.


Our sole intention is to ensure that its consumers get information that is expert-reviewed, accurate, and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover all possible side effects, drug interactions, or warnings or alerts. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.


500 mg


30 Tablet/s, 60 Tablet/s, 90 Tablet/s, 180 Tablet/s


There are no reviews yet.

Be the first to review “Hydrosar”